USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
Objective: To evaluate the impact of rituximab (RTM) therapy on the clinical, morphological, and immunological parameters of lupus nephritis (LN) activity. Subjects and methods. The study included 19 patients with types III and IV LN (WHO classification) with its 6-133-month history. Their mean age...
Saved in:
Main Authors: | Anna Vasilyevna Torgashina, S K Solovyev, E N Aleksandrova, S G Radenska-Lopovok, E L Nasonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2010-08-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1075 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01) -
Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01) -
The role of repeat kidney biopsy in patients with lupus nephritis (case report)
by: N. Yu. Nikishin, et al.
Published: (2024-04-01) -
Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01) -
Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)